Abstract
Cisplatin-based superselective intra-arterial chemotherapy concurrent with radiotherapy (SIART) has been reported to be effective in advanced head and neck carcinomas (HNC). However, the ideal regimen has not been established. We combined nedaplatin (CDGP) with docetaxel (DOC) as a new combination in SIART for treatment of advanced oral squamous cell carcinomas (OSCC). Two patients with stage IV advanced OSCC were treated and complete response (CR) were attained, although a residual metastatic lymph node remained in one case. Thirteen and 10 months post-treatment, no recurrence or metastatic spread was observed. This result indicated that CDGP and DOC combination in SIART is effective in advanced OSCC treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
